This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Stephen Aldrich
Founder at MyCancerDB LLC


Steve Aldrich is the founder of MyCancerDB LLC, a company owned by late-stage cancer patients to help them identify their best available treatment options and better monitor their disease progression and response to treatment.  Steve was also the founder and CEO of Bio Economic Research Associates LLC (bio-eraTM), an independent research and consulting firm that specialized in the social and economic consequences of human-induced change to biological systems.  He lives in Stockbridge, Vermont with his family, where he is supposed to be retired, although he finds time to produce excellent maple syrup and fine apple cider. Steve studied evolutionary biology at Harvard (1978) before entering business.  In 1984, he joined Cambridge Energy Research Associates (CERA) where, with James Newcomb, he co-founded the firm’s natural gas practice.  In 1995, he was appointed to the North American Natural Gas Council.  He left CERA in 1999. In 2002, Steve founded an independent research and consulting firm, Bio Economic Research Associates.  The firm had practice areas in enabling biotechnologies, emerging infectious diseases, bioenergy, and climate change.  Beginning with the publication in 2003 of “SARS and the New Economics of Biosecurity”, bio-era became a leader in the economic analysis of emerging infectious diseases, including H5N1 Avian Influenza and H1N1 pandemic influenza.  Steve was a founding member of the UN “Towards a Safer World” pandemic preparedness network, and has worked with many governments, private sector companies, and NGO’s on pandemic preparedness and response.  He is an author or co-author of numerous articles, books, and reports including:

  • “How Will Synthetic Biology and Conservation Shape the Future of Nature?” (2013)
  • “Bio Genomics and Conservation: Celebrate or Worry? (2009)
  • “H5N1 Update:  What is happening with the Virus and Countermeasure Developments?” (2007)
  • “Genome Synthesis and Design Futures: Implications for the US Economy” (2007)
  • “Recent Advances in Mapping the Evolution and Spread of H5N1”  (2007)
  • “Thinking Ahead: Anticipating Early Impacts of an Avian Influenza Pandemic” (2005)

Agenda Sessions

  • Terminal Patient Gains Control of His Data and Uses It to Create a Fully-Personalized Cancer Therapy